Oruka Therapeutics, Inc. - ORKA

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Mar 27, 2026 SCHEDULE 13G/A The Vanguard Group 0.0% 0 View
Feb 17, 2026 SCHEDULE 13G/A RTW Investments, LP 4.3% 2,058,148 View
Feb 17, 2026 SCHEDULE 13G/A Roderick Wong 4.3% 2,058,148 View
Feb 13, 2026 SCHEDULE 13G/A Deep Track Capital, LP 4.47% 2,161,510 View
Feb 13, 2026 SCHEDULE 13G/A Deep Track Biotechnology Master Fund, Ltd. 3.92% 1,899,455 View
Feb 13, 2026 SCHEDULE 13G/A David Kroin 4.47% 2,161,510 View
Feb 13, 2026 SCHEDULE 13G/A Deep Track Special Opportunities Fund, LP. 0.54% 262,055 View
Jan 30, 2026 SCHEDULE 13G The Vanguard Group 5.06% 2,453,530 View
Jan 21, 2026 SCHEDULE 13G BlackRock, Inc. 6.6% 3,175,483 View
Nov 14, 2025 SCHEDULE 13G/A Venrock Healthcare Capital Partners III, L.P. 9.9% 4,909,619 View
Nov 14, 2025 SCHEDULE 13G/A VHCP Co-Investment Holdings III, LLC 9.9% 4,909,619 View
Nov 14, 2025 SCHEDULE 13G/A Venrock Healthcare Capital Partners EG, L.P. 9.9% 4,909,619 View
Nov 14, 2025 SCHEDULE 13G/A VHCP Management III, LLC 9.9% 4,909,619 View
Nov 14, 2025 SCHEDULE 13G/A VHCP Management EG, LLC 9.9% 4,909,619 View
Nov 14, 2025 SCHEDULE 13G/A Nimish Shah 9.9% 4,909,619 View
Nov 14, 2025 SCHEDULE 13G/A Bong Y. Koh 9.9% 4,909,619 View
Oct 17, 2025 SCHEDULE 13G/A BlackRock, Inc. 4.5% 2,197,517 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.